Evidence map›Paper›PMID 39625074›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Regional cerebral blood flow reflects both neurodegeneration and microvascular integrity across the Alzheimer's continuum.

Mohammad Taghvaei, Sudipto Dolui, Shokufeh Sadaghiani, Banafsheh Shakibajahromi, Christopher Brown, Pulkit Khandelwal, Sharon X Xie, Sandhitsu Das, Paul A Yushkevich, David A Wolk and 1 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad TaghvaeiDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sudipto DoluiDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Shokufeh SadaghianiDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Banafsheh ShakibajahromiDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Christopher BrownDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Pulkit KhandelwalDepartment of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sharon X XieDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sandhitsu DasDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Paul A YushkevichDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David A WolkDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
John A DetreDepartment of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-8115-6343

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology AssociationsR01AG056014 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Paul A. Yushkevich · 2017 to 2026
$4.5M
Characterization of relationship between tau pathology and neurodegeneration in Alzheimer's disease using multimodal imagingR01AG072796 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Sandhitsu Das, DAVID A WOLK · 2022 to 2026
$4.0M
Novel Biomarkers of Small Vessel Contributions to Vascular Cognitive Impairment and Dementia (VCID)R01NS111115 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A, WANG, JIANHUA · 2019 to 2023
$3.7M
Modulators of Medial Temporal Lobe Subregion Structure and Function in Normal and Pathological AgingR01AG055005 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A · 2017 to 2021
$3.3M
Research Training Program in Disease Oriented Neuroscience (R25)R25NS065745 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI DETRE, JOHN A · 2009 to 2023
$3.0M
Academic Industrial Partnership on Advanced Perfusion MRIR01EB031080 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI Yulin V Chang, JOHN A DETRE · 2022 to 2026
$2.7M
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's diseaseR01AG069474 · NIA · UNIVERSITY OF PENNSYLVANIA · PI WOLK, DAVID A, YUSHKEVICH, PAUL A. · 2024 to 2025
$1.4M
Automated Quality Evaluation and Harmonization for Multisite ASL MRI DataR21AG080518 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DOLUI, SUDIPTO, WANG, ZE · 2023 to 2024
$453k
Cerebral Blood Flow trajectory in the Alzheimer's Disease continuumR03AG063213 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DOLUI, SUDIPTO · 2019 to 2020
$323k
Alzheimer's Association AACSF-23-1152241National Institutes of Health (NIH) P30AG072979National Institutes of Health (NIH) R01AG055005National Institutes of Health (NIH) R01AG056014National Institutes of Health (NIH) R01AG069474National Institutes of Health (NIH) R01AG072796National Institutes of Health (NIH) R01EB031080National Institutes of Health (NIH) R01NS111115National Institutes of Health (NIH) R03AG063213National Institutes of Health (NIH) R21AG080518National Institutes of Health (NIH) R25NS065745NIA NIH HHS P30 AG072979NIA NIH HHS R01 AG055005NIA NIH HHS R01 AG056014NIA NIH HHS R01 AG069474NIA NIH HHS R01 AG072796NIA NIH HHS R03 AG063213NIA NIH HHS R21 AG080518NIBIB NIH HHS R01 EB031080NINDS NIH HHS R01 NS111115NINDS NIH HHS R25 NS065745Pennsylvania Department of Health 2019NF4100087335
6 · The paper itself

Abstract

introductionAlzheimer's disease (AD) typically involves both neurodegenerative and vascular pathologies, each associated with reductions in cerebral blood flow (CBF). However, it remains unclear whether vascular and neural contributions to regional CBF can be differentiated.

methodsUsing 3D background-suppressed arterial spin labeled perfusion magnetic resonance imaging, we evaluated regional CBF in a cohort of 257 participants across the AD continuum and assessed the impact of risk factors for both AD and small vessel disease (SVD) on regional CBF.

resultsVascular risk factors (VRFs) were associated with reduced CBF in normal-appearing periventricular white matter, while amyloid positivity was associated with reduced CBF in the posterior cingulate cortex and precuneus. Putative SVD-sensitive regions in white matter exhibited diagnosis-related CBF changes comparable to those in typical AD cortical regions. DISCUSSION: Spatial patterns of hypoperfusion may differentiate AD and VRF-related effects on regional CBF. Our findings also support the contribution of SVD in AD pathogenesis. HIGHLIGHTS: We used 3D background-suppressed pCASL MRI to evaluate CBF across the AD continuum. Putative SVD-sensitive regions in white matter exhibited diagnosis-related CBF changes. AD and/or SVD risk correlated with reduced CBF in AD and/or SVD-related regions. VRFs were associated with more widespread CBF reductions than amyloid positivity. Spatial patterns of hypoperfusion may differentiate AD and VRF-related effects.

Indexed as

Alzheimer DiseaseBrainCerebrovascular CirculationAgedAged, 80 and overCohort StudiesFemaleHumansMagnetic Resonance ImagingMaleRisk FactorsWhite MatterAlzheimer's diseasearterial spin labeling (ASL) MRIcerebral blood flowmild cognitive impairmentsmall vessel diseasevascular risk factor

Identifiers

PMID39625074
PMCPMC11772719

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.